Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Takayasu arteritis (TAK) is a rare chronic inflammatory arteritis, which lacks an effective
well-accepted intervention strategy. Here we tried to classify TAK patients in 3 levels,
including mild, moderate, and severe, and prescribe methotrexate and tofacitinib randomly in
mild and moderate patients, to observe the relatively better treatment strategy, facilitating
better intervention strategy in TAK patients.